首页> 外文期刊>Otology and neurotology: official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology >Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2
【24h】

Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2

机译:2型神经纤维瘤病患者保留耳蜗神经的前庭神经鞘瘤术后同侧人工耳蜗植入

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To investigate the outcomes from ipsilateral simultaneous or sequential cochlear implantation in patients with neurofibromatosis type 2 (NF2) after vestibular schwannoma removal with cochlear nerve preservation. STUDY DESIGN: Retrospective case series. SETTING: Single tertiary referral NF2 center. PATIENTS: Six patients with NF2. INTERVENTION: Removal of vestibular schwannoma (VS) with preservation of the cochlear nerve and cochlear implantation. Four patients had their surgery via a translabyrinthine approach. Two patients had a retrosigmoid approach. A cochlear implant was inserted at the same time as tumor removal in 4 cases and sequentially in 2 cases. MAIN OUTCOME MEASURES: Surgical and audiometric outcomes using Bamford-Kowal-Bench (BKB) and City of New York University (CUNY) sentence scores. RESULTS: The average age at implantation was 24 years (range, 15-36 yr). Follow-up ranged from 5 to 93 months, with an average of 38 months. All patients had useful hearing in the contralateral ear before surgery. One patient gained no benefit from cochlear implantation and proceeded to have an auditory brainstem implant. Of those that had functional cochlear nerves, the average BKB score in quiet was 64%, BKB score in noise was 42%, and CUNY score with lipreading was 97%. Results varied within the group, but all patients gained significant benefit and continue to use their CI at least intermittantly. CONCLUSION: The present series demonstrates that in selected cases, cochlear implantation can be successful after a translabyrinthine approach for VS removal and for restoring hearing after failed retrosigmoid hearing preservation surgery. All patients found the cochlear implant offered useful hearing even in the presence of contralateral hearing.
机译:目的:探讨前庭神经鞘瘤切除术并保留耳蜗神经后同侧同时或序贯人工耳蜗植入治疗2型神经纤维瘤病(NF2)患者的结局。研究设计:回顾性病例系列。单位:单次转诊NF2中心。患者:6例NF2。干预:通过保留耳蜗神经和人工耳蜗,去除前庭神经鞘瘤(VS)。四名患者通过经迷路手术进行了手术。两名患者采用乙状窦后入路。切除肿瘤的同时插入人工耳蜗4例,依次插入2例。主要观察指标:采用Bamford-Kowal-Bench(BKB)和纽约市大学(CUNY)句子评分的手术和听力测量结果。结果:植入时的平均年龄为24岁(范围15-36岁)。随访时间为5到93个月,平均38个月。所有患者术前均在对侧耳内听觉良好。一名患者没有从耳蜗植入中获益,并开始进行听觉脑干植入。在那些具有功能性耳蜗神经的患者中,安静时的BKB平均得分为64%,噪音中的BKB得分为42%,而唇读的CUNY得分为97%。该组中的结果各不相同,但所有患者均受益匪浅,并且至少间歇性地继续使用其CI。结论:本系列研究表明,在某些病例中,经迷路式迷路手术切除VS后和保留乙状窦后的听力恢复手术后,可以成功植入人工耳蜗。所有患者都发现,即使在对侧听力的情况下,人工耳蜗也能提供有用的听力。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号